The transcription factor Lc-Maf participates in Col27a1 regulation during chondrocyte maturation

Experimental Cell Research

Volumn 315, Issue 13, 2009, Pages 2293-2300

  Mayo, Jaime L ^a   Holden, Devin N ^a   Barrow, Jeffery R ^a   Bridgewater, Laura C ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Col11a2; Col27a1; Collagen; Endochondral ossification; Lc Maf; Skeletal development

Indexed keywords

COLLAGEN; COLLAGEN TYPE 11; COLLAGEN TYPE 11A2; COLLAGEN TYPE 2; COLLAGEN TYPE 27A1; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR LC MAF; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL MATURATION; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; ENHANCER REGION; FORELIMB; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; MOUSE EMBRYO; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RADIUS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULNA; UPREGULATION; VASCULARIZATION;

MUS; RATTUS;

EID: 67349101338     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.04.020     Document Type: Article

References (30)

1. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., and Engel J.D. The world according to Maf. Nucleic Acids Res. 25 (1997) 2953-2959
2. Kerppola T.K., and Curran T. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 9 (1994) 3149-3158
3. Dlakic M., Grinberg A.V., Leonard D.A., and Kerppola T.K. DNA sequence-dependent folding determines the divergence in binding specificities between Maf and other bZIP proteins. EMBO J. 20 (2001) 828-840
4. Kataoka K., Noda M., and Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14 (1994) 700-712
5. de Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., and Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19 (2000) 389-394
6. Ho I.C., Hodge M.R., Rooney J.W., and Glimcher L.H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85 (1996) 973-983
7. Huang W., Lu N., Eberspaecher H., and De Crombrugghe B. A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene. J. Biol. Chem. 277 (2002) 50668-50675
8. Kurschner C., and Morgan J.I. The maf proto-oncogene stimulates transcription from multiple sites in a promoter that directs Purkinje neuron-specific gene expression. Mol. Cell. Biol. 15 (1995) 246-254
9. Reza H.M., and Yasuda K. Roles of Maf family proteins in lens development. Dev. Dyn. 229 (2004) 440-448
10. Hale T.K., Myers C., Maitra R., Kolzau T., Nishizawa M., and Braithwaite A.W. Maf transcriptionally activates the mouse p53 promoter and causes a p53-dependent cell death. J. Biol. Chem. 275 (2000) 17991-17999
11. Ho I.C., Lo D., and Glimcher L.H. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188 (1998) 1859-1866
12. Kim J.I., Li T., Ho I.C., Grusby M.J., and Glimcher L.H. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3781-3785
13. Bridgewater L.C., Lefebvre V., and de Crombrugghe B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273 (1998) 14998-15006
14. Bridgewater L.C., Walker M.D., Miller G.C., Ellison T.A., Holsinger L.D., Potter J.L., Jackson T.L., Chen R.K., Winkel V.L., Zhang Z., McKinney S., and de Crombrugghe B. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res. 31 (2003) 1541-1553
15. Jenkins E., Moss J.B., Pace J.M., and Bridgewater L.C. The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol. 24 (2005) 177-184
16. Zhang P., Jimenez S.A., and Stokes D.G. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J. Biol. Chem. 278 (2003) 117-123
17. Omoteyama K., Ikeda H., Imaki J., and Sakai M. Activation of connective tissue growth factor gene by the c-Maf and Lc-Maf transcription factors. Biochem. Biophys. Res. Commun. 339 (2006) 1089-1097
18. MacLean H.E., Kim J.I., Glimcher M.J., Wang J., Kronenberg H.M., and Glimcher L.H. Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev. Biol. 262 (2003) 51-63
19. Tchetina E., Mwale F., and Poole A.R. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J. Bone Miner. Res. 18 (2003) 844-851
20. Pace J.M., Corrado M., Missero C., and Byers P.H. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol. 22 (2003) 3-14
21. Liu Y., Li H., Tanaka K., Tsumaki N., and Yamada Y. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J. Biol. Chem. 275 (2000) 12712-12718
22. Hjorten R., Hansen U., Underwood R.A., Telfer H.E., Fernandes R.J., Krakow D., Sebald E., Wachsmann-Hogiu S., Bruckner P., Jacquet R., Landis W.J., Byers P.H., and Pace J.M. Type XXVII collagen at the transition of cartilage to bone during skeletogenesis. Bone 41 (2007) 535-542
23. Lefebvre V., Zhou G., Mukhopadhyay K., Smith C.N., Zhang Z., Eberspaecher H., Zhou X., Sinha S., Maity S.N., and de Crombrugghe B. An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell. Biol. 16 (1996) 4512-4523
24. Murtaugh L.C., Chyung J.H., and Lassar A.B. Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev. 13 (1999) 225-237
25. Barrow J.R., Thomas K.R., Boussadia-Zahui O., Moore R., Kemler R., Capecchi M.R., and McMahon A.P. Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge. Genes Dev. 17 (2003) 394-409
26. Fernandes R.J., Seegmiller R.E., Nelson W.R., and Eyre D.R. Protein consequences of the Col2a1 C-propeptide mutation in the chondrodysplastic Dmm mouse. Matrix Biol. 22 (2003) 449-453
27. Brown K.S., Cranley R.E., Greene R., Kleinman H.K., and Pennypacker J.P. Disproportionate micromelia (Dmm): an incomplete dominant mouse dwarfism with abnormal cartilage matrix. J. Embryol. Exp. Morphol. 62 (1981) 165-182
28. Seegmiller R.E., Brown K., and Chandrasekhar S. Histochemical, immunofluorescence, and ultrastructural differences in fetal cartilage among three genetically distinct chondrodystrophic mice. Teratology 38 (1988) 579-592
29. Li S.W., Prockop D.J., Helminen H., Fassler R., Lapvetelainen T., Kiraly K., Peltarri A., Arokoski J., Lui H., and Arita M. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev. 9 (1995) 2821-2830
30. Boot-Handford R.P., Tuckwell D.S., Plumb D.A., Rock C.F., and Poulsom R. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J. Biol. Chem. 278 (2003) 31067-31077